methionine has been researched along with Minimal Disease, Residual in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beer, AJ; Coburger, J; Eberhardt, N; König, R; Pala, A; Reske, SN; Scheuerle, A; Schmitz, B; Wirtz, CR | 1 |
| Heidari, P; Loeffler, J; Mahmood, U; Oh, K; Rapalino, O; Shih, HA; Wang, Y | 1 |
| Fukuoka, K; Kuji, I; Matsutani, M; Nishikawa, R; Suzuki, T; Watanabe, Y; Yanagisawa, T | 1 |
| Kageji, T; Kawai, N; Maeda, Y; Miyake, K; Nishiyama, Y; Tamiya, T; Yamamoto, Y | 1 |
| Astner, ST; Grosu, AL; Heinemann, F; Molls, M; Nieder, C; Riedel, E; Schwaiger, M; Weber, WA; Wester, HJ; Wiedenmann, N | 1 |
| Franz, M; Grosu, AL; Gumprecht, H; Jaeger, R; Jeremic, B; Molls, M; Nieder, C; Riedel, E; Schwaiger, M; Weber, WA | 1 |
| Corvilain, B; David, P; Devriendt, D; Dumarey, N; Goldman, S; Heureux, M; Levivier, M; Massager, N; Tang, BN; Wikler, D | 1 |
| Iwama, T; Kato, T; Matsuo, M; Miwa, K; Oka, N; Okumura, A; Shinoda, J; Ueda, T; Yamada, J; Yano, H; Yokoyama, K; Yoshimura, S | 1 |
| Bassa, P; Hicks, K; Inoue, T; Kim, EE; Korkmaz, M; Podoloff, DA; Tansey, W; Wong, FC; Wong, WH; Yang, DJ | 1 |
| Iwata, R; Kubota, K; Reinhardt, MJ; Yaegashi, H; Yamada, S | 1 |
| Rodriguez, M | 1 |
| Barrington, SF; Bullock, P; Cox, T; Maisey, M; Pritchard, D; Robinson, RO; Wilmshurst, JM | 1 |
1 trial(s) available for methionine and Minimal Disease, Residual
| Article | Year |
|---|---|
C11 Methionine PET (MET-PET) Imaging of Glioblastoma for Detecting Postoperative Residual Disease and Response to Chemoradiation Therapy.
Topics: Aged; Chemoradiotherapy; Female; Glioblastoma; Humans; Male; Methionine; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Postoperative Period; Treatment Outcome | 2018 |
11 other study(ies) available for methionine and Minimal Disease, Residual
| Article | Year |
|---|---|
Diagnostic accuracy of intraoperative perfusion-weighted MRI and 5-aminolevulinic acid in relation to contrast-enhanced intraoperative MRI and
Topics: Adult; Aged; Aminolevulinic Acid; Brain Neoplasms; Female; Gadolinium DTPA; Glioblastoma; Humans; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Neoplasm, Residual; Photosensitizing Agents; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tumor Burden | 2019 |
Clinical interpretation of residual uptake in 11C-methionine positron emission tomography after treatment of basal ganglia germ cell tumors: report of 3 cases.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Basal Ganglia; Carbon Radioisotopes; Child; Choriocarcinoma; Combined Modality Therapy; Cranial Irradiation; Craniotomy; Cyclophosphamide; Disease-Free Survival; Etoposide; False Positive Reactions; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lateral Ventricles; Male; Melphalan; Methionine; Neoplasm Recurrence, Local; Neoplasm, Residual; Organoplatinum Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Adjuvant; Remission Induction; Supratentorial Neoplasms; Tissue Distribution; Young Adult | 2015 |
Use of 11C-methionine positron emission tomography in basal germinoma: assessment of treatment response and residual tumor.
Topics: Adolescent; Antineoplastic Agents; Basal Ganglia; Brain Neoplasms; Carbon Radioisotopes; Child; Female; Germinoma; Humans; Magnetic Resonance Imaging; Male; Methionine; Neoplasm, Residual; Positron-Emission Tomography; Prognosis; Thalamus; Treatment Outcome | 2009 |
An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases.
Topics: Brain; Brain Neoplasms; Glioma; Humans; Magnetic Resonance Imaging; Methionine; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Prospective Studies; Sensitivity and Specificity; Time Factors; Tumor Burden; Tyrosine | 2011 |
L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy.
Topics: Adult; Aged; Brain Neoplasms; Female; Gadolinium; Glioma; Humans; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography | 2005 |
11C-methionine PET for the diagnosis and management of recurrent pituitary adenomas.
Topics: Adult; Carbon Radioisotopes; Female; Humans; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Neoplasm, Residual; Pituitary Neoplasms; Positron-Emission Tomography; Recurrence; Sensitivity and Specificity; Treatment Outcome | 2006 |
Simultaneous integrated boost technique by helical tomotherapy for the treatment of glioblastoma multiforme with 11C-methionine PET: report of three cases.
Topics: Adult; Aged; Brain Neoplasms; Carbon Radioisotopes; Female; Glioblastoma; Humans; Male; Methionine; Neoplasm, Residual; Neuronavigation; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Tomography, Spiral Computed | 2008 |
Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine PET in detection of malignant tumors.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Methionine; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed | 1996 |
Assessment of cancer recurrence in residual tumors after fractionated radiotherapy: a comparison of fluorodeoxyglucose, L-methionine and thymidine.
Topics: Animals; Autoradiography; Carbon Radioisotopes; Deoxyglucose; Dose-Response Relationship, Radiation; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Male; Methionine; Neoplasm, Residual; Neoplasms, Experimental; Radiopharmaceuticals; Rats; Thymidine; Tomography, Emission-Computed; Tritium | 1997 |
Computed tomography, magnetic resonance imaging and positron emission tomography in non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Carcinoma; Diagnosis, Differential; Fluorodeoxyglucose F18; Forecasting; Gastroscopy; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Methionine; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Prognosis; Radiopharmaceuticals; Remission Induction; Stomach Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
Positron emission tomography in imaging spinal cord tumors.
Topics: Adolescent; Adult; Carbon Radioisotopes; Child; Child, Preschool; Combined Modality Therapy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Infant; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Neoplasm, Residual; Radiotherapy, Adjuvant; Sensitivity and Specificity; Spinal Cord; Spinal Cord Neoplasms; Tomography, Emission-Computed | 2000 |